Ill.-based Abbott Laboratories Inc. dropped a lawsuit against a French AIDS group on Monday over an alleged cyber-attack against the company’s Web site.
The pharmaceutical and medical products maker filed the lawsuit in May against Act Up-Paris in a Paris criminal court. The company claimed the organization disrupted the company’s Web site for hours on April 26, the eve of its annual meeting.
Activists have been challenging the company over what they consider excessive prices for its AIDS drugs. The North Chicago-based company has been entangled in a standoff over access to its drug Kaletra in Thailand.
“We dropped the suit as ACT Up-Paris acknowledged that communication via our Web site to doctors and patients is important,” Abbott spokeswoman Jennifer Smoter said in a story posted Monday on the Chicago Tribune’s Web site.
Messages left late Monday by the Associated Press for Act-Up Paris and its New York-based sister group Act Up, or AIDS Coalition to Unleash Power, were not immediately returned.
Was this article valuable?
Here are more articles you may enjoy.
U.S. Auto Insurers’ Strong Performance to Continue Through 2025: Fitch 
Florida Insurer Can’t Object to Appraiser After the Award Is Decided, 11th Circuit Says 
Hard Reinsurance Prices Likely to Last Longer Than in Previous Market Cycles: Report 
Wall Street Firms to Pay $470 Million to Settle With US Regulators Over Texting 
